Viltepso® (viltolarsen)
for Duchenne Muscular Dystrophy

Viltepso (viltolarsen) is a treatment for Duchenne muscular dystrophy (DMD) in patients with a confirmed DMD gene mutation amenable to exon 53 skipping. As a Morpholino antisense oligonucleotide, it helps produce dystrophin, a protein essential for muscle function.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Duchenne Muscular Dystrophy